United States — Food and Drug Administration & Rosen Law Firm
13 shared events · Importance 7 · Last updated May 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration sent a warning letter to ImmunityBio regarding misleading efficacy claims made about Anktiva, which triggered the class action lawsuits.
Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that filed the initial securities class action lawsuit against ImmunityBio and is encouraging investors to join.
Apr 02, 2026 · 42 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Disc Medicine, Inc. for its bitopertin program, citing uncertainties in the new drug application.
Rosen Law Firm: Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. and is preparing a class action lawsuit on behalf of investors.
May 01, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's potential non-approval of tabelecleucel's Biologics License Application due to manufacturing issues is a key factor in the lawsuit against Atara Biotherapeutics.
Rosen Law Firm: Rosen Law Firm is representing investors in a class action lawsuit against Atara Biotherapeutics, seeking compensation for alleged damages.
Apr 01, 2026 · 58 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Rosen Law Firm interact across events, view sentiment trends, and discover connected entities.
Open Dashboard